Crinetics Pharmaceuticals, Inc. Deferred Compensation Plan Assets
Crinetics Pharmaceuticals, Inc. (CRNX) had Deferred Compensation Plan Assets of $5.91 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › and Other Assets
us-gaap:DeferredCompensationPlanAssets · last filed 2026-08-03
- 2026-06-30: Deferred Compensation Plan Assets $5.91M.
- 2026-03-31: Deferred Compensation Plan Assets $4.90M.
- 2025-12-31: Deferred Compensation Plan Assets $3.25M.
- 2025-09-30: Deferred Compensation Plan Assets $2.90M.
| Period end | Deferred Compensation Plan Assets |
|---|---|
| 2026-06-30 | $5.91M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $4.90M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $3.25M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $2.90M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $2.35M 10-Q · filed 2025-08-07 |
| 2024-12-31 | $829.00K 10-K · filed 2026-02-26 |